✦ LIBER ✦

Camurati-Engelmann disease type II: Progressive diaphyseal dysplasia with striations of the bones

✍ Scribed by Nishimura, Gen ;Nishimura, Hitoshi ;Tanaka, Yoko ;Makita, Yoshio ;Ikegawa, Shiro ;Ghadami, Mohsen ;Kinoshita, Akira ;Niikawa, Norio

Book ID: 101442823
Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 305 KB
Volume: 107
Category: Article
ISSN: 0148-7299
DOI: 10.1002/ajmg.10079

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Camurati–Engelmann Disease (Progressive

Camurati–Engelmann Disease (Progressive Diaphyseal Dysplasia): Reports of an Indian Kindred

✍ Bhadada, Sanjay Kumar; Sridhar, Subbiah; Steenackers, Ellen; Dhiman, Vandana; Mo 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 485 KB

Marked phenotypic variability in progres

Marked phenotypic variability in progressive diaphyseal dysplasia (Camurati-Engelmann disease): Report of a four-generation pedigree, identification of a mutation in TGFB1, and review

✍ Wallace, Stephanie E. ;Lachman, Ralph S. ;Mekikian, Pertchoui B. ;Bui, Kathy K. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 267 KB

The bisphosphonate zoledronate decreases

The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget’s disease of bone

✍ P Garnero; S Christgau; P.D Delmas 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 77 KB

The role of angiotensin II receptor bloc

The role of angiotensin II receptor blockers in preventing the progression of renal disease in patients with type 2 diabetes

✍ Edmund J Lewis 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 173 KB

Markers for type II collagen breakdown p

Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis

✍ Robert Landewé; Piet Geusens; Maarten Boers; Désirée van der Heijde; Willem Lems 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

## Abstract ## Objective To investigate in a randomized clinical trial setting with an aggressive combination‐therapy arm and a mild‐monotherapy arm, whether therapy‐induced changes in urinary C‐terminal crosslinking telopeptide of type I collagen (CTX‐I) and type II collagen (CTX‐II) predict 5‐ye